1. Home
  2. SKYH vs ALLO Comparison

SKYH vs ALLO Comparison

Compare SKYH & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SKYH
  • ALLO
  • Stock Information
  • Founded
  • SKYH 2017
  • ALLO 2017
  • Country
  • SKYH United States
  • ALLO United States
  • Employees
  • SKYH N/A
  • ALLO N/A
  • Industry
  • SKYH Military/Government/Technical
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SKYH Industrials
  • ALLO Health Care
  • Exchange
  • SKYH Nasdaq
  • ALLO Nasdaq
  • Market Cap
  • SKYH 389.8M
  • ALLO 438.2M
  • IPO Year
  • SKYH N/A
  • ALLO 2018
  • Fundamental
  • Price
  • SKYH $11.36
  • ALLO $1.84
  • Analyst Decision
  • SKYH Strong Buy
  • ALLO Strong Buy
  • Analyst Count
  • SKYH 2
  • ALLO 10
  • Target Price
  • SKYH $15.50
  • ALLO $10.06
  • AVG Volume (30 Days)
  • SKYH 106.7K
  • ALLO 3.0M
  • Earning Date
  • SKYH 11-12-2024
  • ALLO 03-13-2025
  • Dividend Yield
  • SKYH N/A
  • ALLO N/A
  • EPS Growth
  • SKYH N/A
  • ALLO N/A
  • EPS
  • SKYH N/A
  • ALLO N/A
  • Revenue
  • SKYH $12,357,000.00
  • ALLO $43,000.00
  • Revenue This Year
  • SKYH $92.37
  • ALLO N/A
  • Revenue Next Year
  • SKYH $116.98
  • ALLO N/A
  • P/E Ratio
  • SKYH N/A
  • ALLO N/A
  • Revenue Growth
  • SKYH 107.82
  • ALLO 26.47
  • 52 Week Low
  • SKYH $8.26
  • ALLO $1.78
  • 52 Week High
  • SKYH $14.52
  • ALLO $5.78
  • Technical
  • Relative Strength Index (RSI)
  • SKYH 42.32
  • ALLO 37.90
  • Support Level
  • SKYH $10.83
  • ALLO $2.11
  • Resistance Level
  • SKYH $11.68
  • ALLO $2.10
  • Average True Range (ATR)
  • SKYH 0.36
  • ALLO 0.17
  • MACD
  • SKYH -0.05
  • ALLO -0.02
  • Stochastic Oscillator
  • SKYH 38.08
  • ALLO 9.68

About SKYH Sky Harbour Group Corporation

Sky Harbour Group Corp is an aviation infrastructure company building a nationwide network of Home-based solutions for business aircraft. The company develops, leases, and manages business aviation hangars across the United States based on its proprietary targeting and acquisition model, targeting airfields with hangar supply and demand imbalances in the markets. Its hangar campuses feature exclusive private hangars and a full suite of dedicated services specifically designed for home-based aircraft.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, primarily generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: